Development of n-tert-(butyl)hydroxylamine (ntbuha) as a therapeutic agent for treating infantile neuronal ceroid lipofuscinosis (incl)
Active Project Grant Awarded Last action
- Award ID
- R44NS120360
- Recipient
-
Circumvent Pharmaceuticals Inc. UEI Y14DQ5VD56A7
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,178,734
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 88% complete
- Originally
- Funding
-
- $10,736,977.00 Federal
- $1,441,757.00 Non-federal
- Place of performance
- Portland, OR 97239, USA
Award details come from USAspending.gov.
Description
- Abstract
- A significant unmet medical need exists for a therapy to treat patients with infantile neuronal ceroid lipofuscinosis (incl, or CLN1 batten disease.) there are an estimated
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $1,219,273 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,244,790 | $0 | |
| Amendment | $1,244,790 | $0 | |
| Amendment | $1,244,790 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,449,910 | $0 | |
| Amendment | $1,449,910 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,441,757 | $0 | |
| Original award | $1,441,757 | $1,441,757 |
Show all 29
Quick answers
Who received award R44NS120360?
R44NS120360 was awarded to Circumvent Pharmaceuticals Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 20, 2021.
How much is award R44NS120360 worth?
$12,178,734 has been obligated on R44NS120360: $10,736,977 in federal funding and $1,441,757 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award